Boston Scientific (BSX) Long-Term Debt Issuances (2009 - 2025)

Boston Scientific (BSX) has 15 years of Long-Term Debt Issuances data on file, last reported at $1.6 billion in Q1 2025.

• For the quarter ending Q1 2025, Long-Term Debt Issuances fell 27.37% year-over-year to $1.6 billion; the trailing twelve-month figure through Dec 2025 stood at $1.6 billion (down 27.37% YoY), and the FY2025 full-year result was $1.6 billion, down 27.37% from the prior year.
• Long-Term Debt Issuances eased to $1.6 billion in Q1 2025, from $2.1 billion in the prior quarter.
• In the past five years, Long-Term Debt Issuances ranged from a high of $3.3 billion in Q1 2022 to a low of -$1.0 million in Q2 2022.
• A 3-year average of $1.7 billion and a median of $1.9 billion in 2024 frame the typical range for Long-Term Debt Issuances.
• Peak annual rise in Long-Term Debt Issuances reached 27.37% in 2025, while the deepest fall reached 27.37% in 2025.
• Tracing BSX's Long-Term Debt Issuances over 3 years: stood at -$1.0 million in 2022, then surged by 214600.0% to $2.1 billion in 2024, then decreased by 27.37% to $1.6 billion in 2025.
• Business Quant data shows BSX's Long-Term Debt Issuances at $1.6 billion in Q1 2025, $2.1 billion in Q1 2024, and -$1.0 million in Q2 2022.